ADAPT Congress 2012
Outstanding conference with timely topics presented by experts in the field. Very beneficial to me personally, and a great opportunity to meet experts and network for academic
Herbert F., CSO
Sr VP, Health Discovery Corp
Cambridge Healthtech Institute's ADAPT Congress was recently held September 19-21, in Philadelphia, PA.
Key strategic players from across Pharma, Diagnostic, Clinical and Informatics came together to discuss the future of personalized medicine towards a targeted approach. Case studies, discussion groups, short courses and technology highlights were explored. The event, now in its fourth year, featured more than 400 participants, from 20 different countries and more than 195 different organizations (including 24% from Pharma). This year’s attendance offered ample networking opportunities and possible collaborations. More than 50% of the participants were decision makers.
Featured tracks at this year’s event:
Here is what people said about this year’s ADAPT Congress:
Conference provided a great overview for me as a “Companion Diagnostics Newbie”
Principal Regulatory Affairs, Roche Diagnostics
Well organized with a good mix of pharma, Dx, and regulatory representation
Dir & Function Lead Clinical Biomarkers, Daiichi Sankyo Pharma Dev
Come and ADAPT knowledge from the conference into your work!
Cancer Pathobiology & Pathology, Childrens Hospital of Philaldephia